Medical device companies listed in Hong Kong boast impressive overall innovation capabilities, with numerous enterprises anticipated to turn the corner from losses to profits or achieve swift performance growth. Since the start of the year, approximately 18A device companies have witnessed substantial gains, attributed to the introduction of innovative products, technological advancements, and relatively low valuations. Looking ahead, the A-share medical device sector is poised for a turnaround in the second half of the year, fueled by optimized centralized procurement policies, increased production of innovative products, and expansion in international business. This momentum is expected to culminate in high-speed growth during the third quarter.
